Biodontoss and DWC dental implants and superstructures in adults needing tooth replacement
Official title: Post-Market Clinical Follow-Up (PMCF) Study on the Effectiveness and Safety of BIODENTOSS® and DWC® Dental Implants and Superstructures
Run by Değirmenci Otomotiv ve Metal Endüstri A.Ş. · NCT07633665 · Data updated 2026-11-12
This PMCF study tests whether BIODENTOSS and DWC dental implants and their superstructures are safe and effective for adults with tooth loss over 24 months.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 80 (estimated) |
| Sponsor | Değirmenci Otomotiv ve Metal Endüstri A.Ş. Industry-sponsored |
| Locations | 1 site (Konya) |
| Status | Recruiting |
| Started | December 11, 2024 |
| Main results expected | March 31, 2028 |
| Study ends | July 31, 2028 |
| Registry record updated | June 8, 2026 |
| Trial ID | NCT07633665 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18 years or older requiring dental implants, with at least 2 months since tooth extraction and suitable general health for implantation.
✕Probably not a fit
Patients with active systemic conditions or oral health issues that require augmentation or could impair healing may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This prospective, single-center PMCF study follows adults needing dental implants to assess early-term safety and effectiveness of CE-marked BIODENTOSS and DWC implants and their prosthetic components over 24 months. Safety will be measured by tracking complications and adverse events, while efficacy will focus on implant survival, stability, marginal bone loss, chewing function, and oral health-related quality of life. Participants will have 10 study visits, with prosthetic restoration at 3–4 months and final assessment at 24 months post-implantation. The study uses standard implant procedures and collects clinical and patient-centered outcomes to support post-market surveillance. Enrollment targets adults meeting predefined inclusion criteria and excluding conditions that could confound healing or demonstrate the implant's performance in real-world settings.
Why it matters
Potential benefit: If successful, patients may experience reliable tooth replacement with favorable implant stability and improved function and quality of life.
How similar studies have gone: PMCF-style evaluations of dental implants have shown variable safety and effectiveness, with some studies reporting favorable osseointegration and stability in CE-marked systems.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18 years of age or older, * Male or female, * Subjects with missing tooth who require dental implant treatment, * At least 2 months elapsed since tooth extraction, * General health status suitable for implantation, * Not legally restricted (e.g., soldier, convict), * Provision of signed Informed Consent Form (ICF) Exclusion Criteria: * Suspected or confirmed pregnancy or breastfeeding, * Disorders preventing adequate daily oral hygiene, * Hypersensitivity/allergy to titanium or implant components, * Inappropriate interarch relationship or parafunction (e.g., bruxism), * Bone/soft tissue deficiency requiring augmentation, * Active periodontal infection or untreated oral pathologies, * Unstable systemic diseases affecting wound healing (e.g., diabetes), * Use of immunosuppressive drug therapy due to systemic disorders, organ transplantation, or any other medical conditions, * Hematological disorders or current use of anticoagulants (such as Warfarin, dabigatran or related therapies), * Presence of osteoporosis and/or any disease condition affecting bone metabolism, * Presence of an active systemic infection, or any health condition or ongoing treatment (e.g., radiotherapy, bisphosphonate therapy) that contraindicates elective surgery, * Recent myocardial infarction or cerebrovascular event, * Individuals who consume high doses of alcohol, cigarettes, or tobacco products and are unable to control their usage, * Participation in another interventional clinical study.
Where it's running
-
Selcuk University, Faculty of Dentistry, Dept. of Oral and Maxillofacial Surgery.
Konya, Turkey (Türkiye) Recruiting
Study contacts
- Principal investigator: Abdullah Kalayci, Professor — Selcuk University Faculty of Dentistry
- Study coordinator: Abdullah Sari, Met. Eng.
- Email: kaliteyonetimi@dome.com.tr
- Phone: +90 (332) 516 16 91
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Comparing one-piece and two-piece ceramic dental implants for tooth loss
This study is testing whether one-piece or two-piece ceramic dental implants work better for adults with missing teeth and if there are any problems with each type.
-
Dental Abutments With Different Surfaces in Two-Unit Implant Bridges
This study tests whether two different abutment surface types affect outcomes for people needing two-implant-supported, two-unit bridges in the back of the mouth.
-
Accuracy of the Calibrated Framework for Full-Arch Implant Impressions in Edentulous Patients
This study tests whether digital scanning with a calibrated framework can match the accuracy of traditional splinted impressions for full-arch dental implants in completely toothless patients.
-
Effect of four post-extraction socket approaches on preserving the ridge after tooth removal
This study tests four ways to care for an extraction socket to see which best preserves the jawbone and gum after tooth removal for future implants.
-
Immediate molar implants with customized healing abutments in different socket classes
This study tests placing an implant right after extracting a back tooth and using a custom healing cap to shape the gum from day one, in people needing posterior implants.
-
Use of enamel matrix derivative with immediate implants in the lower back teeth
This trial tests whether applying enamel matrix derivative at the time of immediate mandibular molar implants helps osseointegration and healing.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.